The Role of Doublecortin-like in the Suprachiasmatic Nucleus by Polm, Boris
The Role of Doublecortin-like in the Suprachiasmatic 
Nucleus 
 
Boris Polm 
Leiden University Medical Center 
b.t.polm@lumc.nl 
 
 
 
ABSTRACT 
The hypothalamic Suprachiasmatic Nucleus (SCN) is 
known as the central biological clock that regulates 
circadian rhythmicity in mammals. Through vasopressin 
(AVP) processing in its shell, the SCN signals to other 
brain areas and peripheral organs in the body. A novel 
protein, Doublecortin-like (DCL) was identified to have 
overlapping expression with that of AVP. Mice with 
SCN-specific DCL-knockdown  show abnormal activity 
adaption after a change in light-phase, and 
immunohistochemical AVP staining indicate a distortion 
of AVP in the SCN of DCL-knockdown mice. Together, 
we conclude that DCL may be a novel regulator of AVP 
signalling in the SCN. 
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INTRODUCTION 
As most living organisms, humans have a circadian cycle 
guided by an intrinsic biological clock  [1]. In mammals, 
this biological clock is located in the suprachiasmatic 
nucleus (SCN), within the hypothalamus in the brain. The 
SCN is composed of two areas working together: the 
shell and the core [2]. Information from the retina is 
processed by the core through the neurotransmitter 
Vasoactive Intestinal Peptide (VIP). Subsequently, 
GABAergic signaling transmits information from the core 
to the shell. The shell is the external feature of the SCN 
and regulates the excretion of vasopressin (AVP) [3] [4]. 
AVP is both an external and an internal mediator of the 
SCN. The external functions of AVP include the 
activation of distant brain areas and the control of the 
expression other hormones. The internal function is for 
intracellular communication within the SCN.  
 The biological clock works on a molecular level: within 
the SCN the changing balance of gene-expression forms a 
rhythm in each individual neuron. In normal 
circumstances, this is a 24-hour rhythm, but a change in 
environment can cause a shift in rhythm. This shift causes 
the biological clock to adapt. Humans experience this as a 
jetlag. Many previous studies show phase-shifts in mice 
where the day-night rhythm is changed [5]. Other factors 
also influence the circadian rhythm, including locomotor 
activity, food uptake and direct release of hormones like 
cortisol and serotonin.  
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The analysis of biological rhythms in the SCN is very 
important for understanding the role of the SCN. Animal 
models are observed for neuronal and gene activity and this 
is linked to locomotor activity and changes in phenotype.  
The ability to adapt to changes in rhythm is due to 
neuroplasticity of the SCN. This report focusses on a 
specific neuroplasticity protein, doublecortin-like (DCL), 
which is a member of the doublecortin-family. Recent 
studies by Saaltink et al. show the importance of this 
family within the SCN [6]. 
Doublecortin (DCX), which is similar in length and shares 
a high number of amino acids with DCL, is a protein 
associated with the formation of microtubules. It is 
expressed by neuronal precursor cells and immature 
neurons [7]. DCX is often used as a marker for 
neurogenesis, using labeled antibodies against DCX. 
Doublecortin is a Microtubule Associate Protein (MAP). 
Doublecortin-like kinase 1 (DCLK1), a member of the 
DCX family, has a splice variant highly homologue to 
DCX [8]. The resulting protein is therefore called DCL [9] 
[10]. Its known function lies in microtubule stabilization 
within mitotic spindles. However, the role of DCL in the 
SCN is mostly unknown  and under investigation. 
Mouse models are commonly used in circadian research. 
Although mice are nocturnal animals, the activity of the 
SCN is reversed, and therefore equal to that of diurnal 
animals [11]. DCL knockdown mice have been developed 
by the LUMC neurophysiology lab, in which the 
knockdown can be triggered through doxycycline (dox) 
ingestion. Saaltink et al. developed a reverse tetracycline 
(doxycycline)-controlled transactivator (rtTA) regulated 
model [12]. Using these mice, they have shown that the 
knockdown of DCL resulted in an inhibition of neuronal 
proliferation and hence, an inhibition of neurogenesis. 
Therefore, it can be expected that DCL knockdown mice 
will have lowered neuroplasticity and will react to 
environmental changes in a less profound fashion. 
The aim of this study is to discover the role of DCL in 
the SCN using DCL-knockdown mice. The primary 
hypothesis is that the DCL knockdown mice have an 
altered reaction to photoperiodic changes, due to 
alteration in the expression of vasopressin.  
 
METHODS 
Mouse model 
For these experiments, the DCL-knockdown mice as bred 
by Saaltink et al. were used. Experiments were approved 
by the Animal Experiments Ethical Committee of Leiden 
University. The following setup was used:  
4 groups of mice were treated: one DCL-knockdown group 
and one wildtype group fed with a doxycycline diet and a 
transgenic- and wildtype-group on normal diet as controls. 
The mice were exposed to different sets of photoperiods, as 
shown in figure 1. Two relevant shifts were performed: a 
shift from 12:12 light:dark (LD) to 8:16 LD and a shift to 
total darkness (DD), also called freerunning. The 
locomotor activity of the mice was recorded [13] using 
Passive Infrared Registration (PIR) sensors and these 
recordings were available for analysis by the software 
program ‘Clocklab’, in the form of actograms (figure 1). 
 
Clocklab 
The Actimetrics developed application Clocklab is 
routinely used to analyze actograms. Using this program a 
straight line through the onsets and offsets was drawn. In 
this way, the tau of each individual mouse was calculated. 
By definition, the tau is the duration of a single cycle, 
from the onset of the active period of day n until the onset 
of the active period of day n+1. In normal rhythm, this 
would be 24 hours, as it is light controlled, but during a 
phase shift, tau is an indication of neuroplasticity. 
 
SPSS analysis 
In SPSS the data from all the mice were divided into four 
groups: transgenic mice with chow (transgenic chow 
group); transgenic mice with doxycycline (transgenic 
doxycycline group); wildtype mice with chow (wildtype 
chow group); and wildtype mice with doxycycline 
(wildtype doxycycline group). Using one-way ANOVA 
analysis differences between the groups were analyzed, 
giving an F-value. The F-value is a ratio between two 
mean squares, equal groups are therefore expected to 
have an F-value of around 1 and a higher F-value shows a 
bigger difference between the groups. To find intergroup 
differences, a Post-hoc Tukey HSD test was performed. 
Furthermore, using independent t-tests differences 
between both diets and mouse-lines were examined. 
Given p values are 2-tailed and p<0,05 was considered 
statistically significant. Note that all SPSS analysis was 
performed while the experimenter was blind with respect 
to the background of the animals, in order to overcome 
bias. 
 
Immunohistochemical staining 
The brains sere extracted and stored in 30% sacharose in 
0,1M TBS with soda-azide. Subsequently, the brains were 
sectioned in 30 µm thick slices in a cryostat at -23ºC. 
After cutting, the slices were stored in an anti-freeze 
solution containing 40% 0,1 M TBS, 30% ethylene glycol 
and 30% glycerol. The slices were frozen for staining at -
20ºC.  
Immunohistochemistry was performed to detect 
expression of DCL, AVP and VIP in the SCN. For DCL  
a novel primary antibody was generated by injecting a 
rabbit with 18‐amino acid long synthetic peptide 
(QRDLYRPLSSDDLDSVG‐C), which is the 6th and 7th 
exon of DCLK1 and resembles the C-terminus of DCL. 
The obtained polyclonal antibody that was formed by the 
rabbit was used and has been described in detail [6]. The 
primary antibodies for AVP and VIP are also polyclonal 
rabbit antibodies: rabbit-anti-AVP (AB1565, EMD 
millipore) and rabbit-anti-VIP (T-4246, Peninsula 
Laboratories International, Inc.). As a secondary antibody, 
Alexa fluor 594 goat-anti-rabbit (A11037) was used to 
visualise three primary antibodies. 
 
Microscopy 
Using a Leica DM5500 epifluorescence microscope and 
Leica SP8 confocal laser scanning microscope (Leica 
Microsystems, Rijswijk, the Netherlands) fluorescence was 
observed. Using the DAPI stain and the Mouse Brain Atlas 
as orientation, the SCN was localized. Photos were taken 
of the results using an attached Leica DFC450 camera. 
Image Pro Plus was used to cells and to quantify 
corresponding fluorescent intensities. ImageJ calculates the 
intensity of each pixel, which corresponds to the local 
fluorescence and thus the presence of the target protein. 
For all three antibodies the area of the full SCN was 
isolated and a pixel-intensity count was performed. A 
background area was extracted. For the AVP-antibody an 
intensity count was performed on cellular level. Per slide, 
15 full cell bodies were selected and the mean intensity of 
these cellbodies were calculated. This measurement is 
semi-quantitative, as exact localisation of every SCN 
neuron may vary from section to section and also the 
immunohistochemical procedure may vary from sample to 
sample. However, the resulting data gives a solid indication 
of the quantity in which the protein is present. 
 
RESULTS 
During analysis of the data, no significant difference was 
found between the three control groups in any of the 
experiments. For this reason the DCL-knockdown mice are 
compared to the wildtype mice on doxycycline in all 
figures. Note that the analysis has been performed for all 
groups. 
 
Phase shift from 12:12 LD to 8:16 LD 
To analyse possible statistically significant differences in 
circadian function between the different mouse groups 
during the 8:16 LD period, the data is analysed using a 
one-way ANOVA. For the onset tau, a significant 
difference between DCL-knockdown mice and controls is 
found, with values of F(3, 31) = 42,841, p < 0,0001. This 
significant difference is shown in figure 2b.  
 
Phase shift to DD 
A similar ANOVA analysis is performed to find significant 
differences between the mouse groups after the switch to 
full darkness (DD, freerunning). The mean difference 
between groups is compared for the onset tau, and a 
significant difference with values of F(3, 29)=6,435, 
Figure 2: Actogram showing the experimental setup. Gray bars 
indicate darkness, white bars indicate light in the cage. Black 
bars indicate activity of the mouse. Each horizontal line consists 
of 48 hours. 
Figure 1: A: mean onset tau during the first 10 days of the 8:16 
LD photoperiod. p<0,0001. B: mean onset tau during the last 
10 days of DD (freerunning) photoperiod. p=0,002. 
p=0,002 is found. This significant difference is shown in 
figure 2a. 
Furthermore, looking at the first five days of freerunning, 
the change in the active phase, per day is found by 
subtracting the onset from the offset. If the result is a 
positive number, it means that the active period becomes 
longer by this number each day. The change of active 
period per day was analyzed per group. First of all, a 
normal distribution is found in all groups. The mean 
difference between groups is compared and a significant 
difference between knockdown mice and controls is 
found, with a value of F(3,29)=19,502 p<0,001. (data not 
shown) 
 
Immunohistochemistry 
Independent t-test of intensity measurements of photos of 
DCL in the SCN shows a difference of 59,37 (±4,980)% 
between the DCL knockdown mice and the control 
groups. (data not shown) 
The fluorescent intensity of AVP staining in the SCN 
showed no significant difference within the whole SCN 
(data not shown). However, a difference in histology was 
observed. AVP was more concentrated in the cells of the 
knockdown mice, but not outside the cells. This shows 
that the distribution of AVP is altered between the 
knockdown mice and the control mice. To test this, 
fluorescence was analyzed for the individual cells and a 
significant increase in fluorescence within the cells was 
found between the knockdown mice and the control mice 
(figure 3). The figures show that there is a buildup of 
AVP within the cells of the DCL knockdown, but no 
spreading around the cells. 
No significant difference was found comparing VIP 
expression in SCN of knockdown mice and controls. 
(data not shown). 
 
DISCUSSION 
The results show that DCL-knockdown mice have an 
altered response to light changes and a different 
localization of AVP expression in the SCN. This is the 
first study finding that a structural protein (DCL) is of 
crucial importance for the circadian functioning of the 
SCN. 
 
Phase shift measurements 
The results from both the switch to 8:16 LD and the 
freerunning period show a much lower tau in the DCL-
knockdown mice. During freerunning, all three groups of 
control mice stay close to the normal rhythm, with tau of 
around 23,9 hours, while the knockdown group has a tau of 
23,7 hours, which was significantly different from the 
control groups. These data indicate that the DCL-
knockdown mice are less successfully able to stay in 
rhythm. Rhythm patterns also suggest a gradual loss of 
rhythm, during the first 5 days of freerunning (data not 
shown). Similar findings were reported in AVP-receptor 
knockout mice [14]. These findings agree with our 
hypothesis that the knockdown mice have a fastened 
reaction to environmental change due to change in 
expression of AVP.  
 
Immunohistochemical staining of the SCN 
Analysis of the immunohistochemical staining of DCL in 
the SCN indicates that induced DCL-knockdown was 
effective. The transgenic mice show a 60 percent 
knockdown of DCL. This percentage can be regulated 
through changes in diet, adding more doxycycline to the 
food will result in lower DCL expression. 
Furthermore, the immunohistochemical staining of AVP in 
the SCN shows significantly heightened AVP expression 
inside the SCN cellbodies of the knockdown mice, but low 
expression in axons and varicosities. Overall expression of 
AVP does not seem to change in the SCN. This suggests a 
key role of DCL in the transport of AVP from the cellbody 
to the protrusions. This observation is supported by 
research by Yoshiaki et al. who found similar actograms 
from their AVP-receptor knockout mice [14] and the 
similar anatomical locations of DCL and AVP. 
AVP does not seem to co-localize with DCL and high 
magnification of DCL-AVP double fluorescence staining 
suggests the expression in other cells than AVP (shown by 
a fellow student, data not shown). DCL-positive cells 
surround AVP cells in a way similarly seen in glial cells 
[15]. For this reason, we believe that the DCL-positive 
cells are actually astrocytes. The mechanism in which the 
astrocytes control the transport of AVP from the cellbody 
to the varicosities is unknown, but we can suggest two 
possible mechanism. The first mechanism is through the 
expression of ATP. ATP is released by astrocytes in a 
circadian rhythm [16] along the cellbodies of the AVP-
cells. ATP could induce a pathway controlling AVP release 
to the axons. DCL would regulate the transport of ATP in 
the astrocyte, in this model. A second possible mechanism 
would be mechanical. The astrocytes surrounding the 
AVP-cell could mechanically push the cell to transport 
Figure 3: Immunohistochemical AVP staining and fluorescence analysis of the SCN. A: Illustrative example of a control mouse, magn. 
40x. Fluorescence shows distributed inside the cell and spreading outside the cell. E: Illustrative example of DCL knockdown mouse, 
magn. 40x. Fluorescence shows concentrated to inside the cells mainly, with less spreading outside the cells. F: Significant differences 
found between DCL knockdown mice and control mice showing that there is more DCL inside the SCN cells of the knockdown mice 
than in the SCN cells of the control mice (p=0,0052).  
 
AVP along the axon in a similar way as GnRH release is 
physically controlled by tanycytes [17]. In this model, 
DCL acts as a structural protein. In both models, the 
change in AVP expression after DCL-knockdown is 
explained. 
Finally, immunohistochemical VIP staining has shown no 
differences between the knockdown mice and the 
controls, indicating that DCL does not influence 
expression and subcellular localization of this 
neurotransmitter. Our VIP findings are in line with our 
hypothesis, because the expression of VIP is in the core 
of the SCN rather than the shell, where DCL is expressed. 
However, AVP staining shows a network of AVP-
positive axons through the core of the SCN where VIP-
neurons are located. Change in expression of AVP could 
result in a changed regulation of VIP. Though we find no 
change in fluorescence of the VIP cells, the rhythm of 
VIP cells might be changed in DCL-knockdown mice.   
 
CONCLUSION 
The downregulation of DCL in mice shows a change in 
activity pattern similar to AVP or VIP knockdown mice.  
Furthermore, the immunohistochemical fluorescent 
staining of the SCN shows an increase of AVP within the 
cellbody and a decrease of AVP in axons and varicosities 
while there is no change in VIP. Increased AVP 
localization on the one hand and decreased localization in 
axons and varicosities on the other hand suggests that 
DCL influences transport of AVP from the cell body to 
the protrusions. As earlier studies show no co-localization 
between DCL and AVP, DCL is not actively bound to 
AVP during this transport. Future research may focus at 
the transport of AVP in more detail, in order to find the 
exact function of DCL. Also, the type of cell in which 
DCL is active should be identified, to see whether it are 
indeed astrocytes. Another interesting study would be to 
look at whether there is circadian rhythmicity in the 
concentration of DCL in the SCN. As so many proteins 
and compounds have a rhythm, especially in the SCN, the 
changes in level of DCL might be a good indication of the 
role and mechanism of the protein in the SCN. In order to 
examine the mechanisms in which AVP transport could 
be regulate, I recommend looking at ATP expression of 
DCL-positive cells, as well as the role ATP plays on 
AVP-cells.  
This study has given new insights in the functioning of 
DCL and a better understanding of the mechanisms of the 
biological clock. It also shows DCL as a possible clinical 
target for AVP regulation and therefore as a 
pharmaceutical target for medication against jetlag and 
sleep-cycle related diseases, as earlier described by 
Yoshiaki et al.. For the time being, this study sheds the 
first light on DCL in the SCN, but many more steps 
should be taken to fully understand the role protein. 
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